CAS 61177-44-4

4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, lithium salt (1:1), (2R,3Z,5R)-

Description:

4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, lithium salt (1:1), (2R,3Z,5R)- is a complex organic compound characterized by its bicyclic structure, which includes both nitrogen and oxygen heteroatoms. The presence of a carboxylic acid functional group indicates potential acidity and reactivity, while the lithium salt form suggests enhanced solubility and stability in various solvents. The specific stereochemistry denoted by (2R,3Z,5R) implies that the compound has defined spatial arrangements, which can influence its biological activity and interaction with other molecules. This compound may exhibit properties typical of both bicyclic amines and carboxylic acids, potentially making it useful in pharmaceutical applications or as a biochemical probe. Its unique structure could also confer specific binding affinities or catalytic properties, depending on the context of its use. Overall, the compound's characteristics are shaped by its intricate molecular architecture and functional groups, which dictate its chemical behavior and potential applications.

Formula: C₈H₉NO₅·Li

InChI: InChI=1S/C8H9NO5.Li/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4;/h1,6-7,10H,2-3H2,(H,12,13);/b4-1-;/t6-,7-;/m1./s1

InChI key: InChIKey=NFFXIXWEWBDWBZ-JSYANWSFSA-N

SMILES: C(O)(=O)[C@@H]\1N2[C@](O/C1=C\CO)(CC2=O)[H].[Li]

Synonyms:

• 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, lithium salt (1:1), (2R,3Z,5R)-
• 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, (2R,3Z,5R)-
• 4-Oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, monolithium salt, [2R-(2α,3Z,5α)]-
• Lithium (2R-(2alpha,3(Z),5alpha))-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo(3.2.0)heptane-2-carboxylate
• Lithium clavulanate

LITHIUM CLAVULANATE CRS

CAS: 61177-44-4

LITHIUM CLAVULANATE CRS

Formula: C₈H₈LiNO₅

Molecular weight: 205.0938

Ref: 41-L0720000

Clavulanate Lithium

CAS: 61177-44-4

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formula: C₈H₈NO₅·Li

Color and Shape: White Light Yellow Powder

Molecular weight: 205.05625

Ref: 45-1134426

lithium [2R-(2α,3(Z),5α)]-3-(2-hydroxyethylidene)-4-oxa-7-oxo-1-azabicyclo[3.2.0]heptane-2-carboxylate

CAS: 61177-44-4

Formula: C₈H₈LiNO₅

Purity: 97%

Color and Shape: Solid

Molecular weight: 205.0938

Ref: IN-DA00EF4Z

Clavulanate lithium

CAS: 61177-44-4

Clavulanate lithium (Clavulanic acid lithium) is an inhibitor of β-lactamase.

Formula: C₈H₈LiNO₅

Purity: 99.79%

Color and Shape: Solid

Molecular weight: 205.09

Ref: TM-T14979

Clavulanate Lithium

CAS: 61177-44-4

Formula: C₈H₈NO₅·Li

Color and Shape: White To Off-White Solid

Molecular weight: 198.16 6.94

Ref: 4Z-C-3213

Clavulanate lithium

CAS: 61177-44-4

Clavulanate lithium

Purity: ≥98%

Molecular weight: 205.09g/mol

Ref: 54-BUP06254

Clavulanic acid lithium salt

CAS: 61177-44-4

Ref: 7W-GK2046

Clavulanate Lithium

Controlled Product

CAS: 61177-44-4

Stability Hygroscopic
Applications Clavulanate Lithium is used as an antibacterial compound against a β-lactamase producing strain of Staphylococcus aureus.
References Cuffini, A. et al.: Microbios., 87, 31 (1996); Rodriguez, M. et al.: Int. J. Antimicrob. Agents., 29 332 (2007);

Formula: C₈H₈NO₅·Li

Color and Shape: Off-White

Molecular weight: 205.09

Ref: TR-C563740

Clavulanate Lithium

CAS: 61177-44-4

Clavulanate lithium is an antibiotic that inhibits the growth of bacteria by binding to penicillin-binding proteins. It is a prodrug that is hydrolyzed in vivo to clavulanic acid, its active form. The inhibitory properties of clavulanate lithium are similar to those of amoxicillin, but it has greater activity against pseudomonas aeruginosa and Staphylococcus aureus. Clavulanate lithium has been shown to increase the plasma concentrations of amoxicillin when used in combination with this drug. It is also effective against a variety of bacterial infections, including Escherichia coli, Proteus mirabilis, Enterobacter cloacae, and Staphylococcus aureus isolates. Clavulanate lithium can be used as an adjunct therapy for the treatment of respiratory tract infections caused by common viruses such as influenza and rhinovirus. Clavulanate

Formula: C₈H₉NO₅•Li

Purity: Min. 95%

Color and Shape: Powder

Molecular weight: 206.1 g/mol

Ref: 3D-FC46584

Lithium Clavulanate

CAS: 61177-44-4

Formula: C₈H₈NO₅Li

Molecular weight: 198.15 : 6.94

Ref: ST-EA-CP-C24015